Douglas Marchion, PhD
Research Scientist
H. Lee Moffitt Cancer Center
12902 Magnolia Dr
Tampa,
FL
USA
33612
Papers:
181
Molecular signaling pathways associated with squamous-cell carcinoma of the cervix cisplatin-resistance
286
Unique molecular portraits of ovarian cancer: implications for prognostics and targeted therapeutics
340
AKT survival signaling and phospho-AKT expression are associated with triple negative breast cancer development and clinical outcome
361
The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival
437
AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome
441
Vitamin D suppresses ovarian cancer invasion by inhibiting cytokine expression and NFκB signaling
471
Distance to specialist care is associated with survival in patients with gynecologic malignancies
515
Repurposing Artesunate, an anti-malarial, for ovarian cancer treatment: mechanistic insights from cell line models